Skip to main content
48°
Rain
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Tevogen Bio Holdings Inc. - Common Stock
(NQ:
TVGN
)
1.640
+0.220 (+15.49%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tevogen Bio Holdings Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Tevogen Bio CEO Reflects on Public Support, Reaffirms Preserving Shareholder Value Remains His Priority, and Reinforces Options Including a Potential Share Buyback to Support Company Value
Today 15:59 EST
From
Tevogen Bio Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 20, 2024
Via
Benzinga
Why Keysight Technologies Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
November 20, 2024
Via
Benzinga
Tevogen Bio Reports Third Quarter 2024 Financial Results; Highlights Significantly Improved Financial Position, Unreported Asset Value on Balance Sheets, Efficient Business Model
November 19, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
UPDATE - Tevogen Founder Reflects on Importance of Preserving Shareholder Value While Navigating Growth as it Prepares to File Quarterly Financials
November 14, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Founder Reflects on Importance of Preserving Shareholder Value While Navigating Growth as it Prepares to File Quarterly Financials
November 14, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio Shares Are On The Rise Monday: What's Going On?
November 11, 2024
Tevogen Bio Holdings Inc. (NASDAQ: TVGN) shares are trading higher Monday, potentially driven by momentum from a late-Friday announcement regarding operational updates. Here's what you need to know.
Via
Benzinga
Tevogen Bio Nears Finalization of Agreement to Enhance R&D and Manufacturing Capabilities; $36 Million Line of Credit Available for Continued Operations
November 08, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio CEO Dr. Ryan Saadi Expresses Gratitude for Prestigious ROI-NJ Recognition, Highlighting Company’s Novel Business Model as Key to Sustainable Success through Patient Affordability
November 05, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio Leverages Microsoft Partnership to Deliver Machine Learning Based Target Identification to Address Human Papilloma Virus (HPV), Advancing TVGN 920
November 05, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio Announces Appointment of Anthony Tarantino as Patient Advocate to Enhance Community Engagement and Patient Support
November 04, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
November 04, 2024
Via
Benzinga
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In October 2024 — Where Do Tesla, Nvidia, Apple, DJT Stock Rank?
November 04, 2024
A look at the most-searched tickers on Benzinga Pro for the month of October. Donald Trump and biotech stocks joined the top 10.
Via
Benzinga
Topics
Government
Exposures
Political
Tevogen Bio Expands on Microsoft Partnership to Integrate Machine Learning and AI into Preclinical Processes, Accelerating Drug Development and Reducing Costs
October 31, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio Reports Nasdaq Listing Compliance as CEO Reaffirms His Commitment in Bridging the Information Gap About the Company
October 29, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio Signs Letter of Intent With CD8 Technology to Build Up to a $50 Million R&D and Manufacturing Facility; No Impact on Shareholder Equity
October 29, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
October 28, 2024
Via
Benzinga
Philips Posts Weak Earnings, Joins Clear Channel Outdoor And Other Big Stocks Moving Lower In Monday's Pre-Market Session
October 28, 2024
Via
Benzinga
Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
October 28, 2024
Via
Benzinga
Tevogen Bio Provides Additional Guidance on Introduction of T Cell Therapy for Oncology and Specialty Care Therapeutic Areas
October 25, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Capri, Coursera, DexCom And Other Big Stocks Moving Lower In Friday's Pre-Market Session
October 25, 2024
Via
Benzinga
Early Movers: PRSO, TVGN, ZENA, CCTG, CRDL Stocks to Watch Today!
October 24, 2024
Via
AB Newswire
Topics
Artificial Intelligence
Intellectual Property
Exposures
Artificial Intelligence
Intellectual Property
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 24, 2024
Via
Benzinga
Tevogen Bio Shares Are Soaring Wednesday: What's Going On?
October 23, 2024
Tevogen Bio Holdings Inc. (NASDAQ:TVGN) stock is moving higher on Wednesday after the company announced its artificial intelligence effort, Tevogen AI, has joined Microsoft Corporation (NASDAQ:MSFT)...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 23, 2024
Via
Benzinga
Tevogen Bio’s Effort in Artificial Intelligence, Tevogen AI, Joins Microsoft for Startups, Begins Accelerating drug Development
October 23, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio To Provide Timelines Associated with Recently Announced Revenue Forecast and Updates on Operational Readiness This Week
October 22, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio Specialty Care Reports Top-Line Revenue Forecast of Nearly $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $18 Billion and $22 Billion
October 21, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio Provides Clarity on CSO Share Sales to Satisfy Tax Obligations, Expects Additional Forecast and Progress Updates in the Coming Days
October 21, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen CEO Expresses Gratitude for Unprecedented Public Support of Company’s Business Model of Commercial Success Through Patient Accessibility and Reaffirms His Commitment to Share Additional Details in the Coming Days
October 18, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.